[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6561-6562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02412]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the National Lung Hospital (NLH)/National Tuberculosis Program, Vietnam

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $1,500,000, for Year 1 of funding to the 
National Lung Hospital (NLH)/National Tuberculosis Program (NTP). The 
award will support high quality TB, multi-drug resistant TB (MDR-TB), 
and TB/HIV programs to strengthen and expand TB and MDR-TB quality-
assured diagnostic capacity

[[Page 6562]]

(clinical and laboratory testing); promote TB, MDR-TB, and TB/HIV 
prevention and integration into existing healthcare services; 
strengthen TB surveillance and monitoring and evaluation (M&E) and 
improve collaboration and coordination between TB and other programs, 
particularly HIV and COVID-19. Funding amounts for years 2-5 will be 
set at continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Amy Bailey, Center for Global Health, 
Centers for Disease Control and Prevention, 5th/Floor Tung Shing 
Building, No 2, Ngo Quyen Street, Hoan Kiem District Hanoi, Vietnam, 
Telephone: 800-232-6348, email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will contribute to 
enhancing early and universal access to high quality prevention, 
diagnosis, and treatment services for TB, MDR-TB, and TB/HIV with the 
goal of ending TB in Vietnam by 2030.
    The NLH/NTP is in a unique position to conduct this work as it is 
mandated by Vietnam Ministry of Health (MoH) with oversight and 
implementation of TB prevention and control activities in Vietnam. The 
NLH is the leading tertiary hospital in charge of examination and 
treatment of TB and lung diseases and steering TB and lung disease 
prevention and control activities throughout the country.

Summary of the Award

    Recipient: National Lung Hospital (NLH)/National Tuberculosis 
Program (NTP).
    Purpose of the Award: The purpose of this award is to support high 
quality TB, MDR-TB, and TB/HIV programs to strengthen and expand TB and 
MDR-TB quality-assured diagnostic capacity (clinical and laboratory 
testing); promote TB, MDR-TB, and TB/HIV prevention and integration 
into existing healthcare services; strengthen TB surveillance and M&E 
and improve collaboration and coordination between TB and other 
programs, particularly HIV and COVID-19.
    Amount of Award: The approximate year 1 funding amount will be 
$1,500,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02412 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P